col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Mary Ann Liebert: GEN Edge
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―28 Pick Up the Pieces: Invivyd Engineers New COVID-19 Monoclonal Candidate Alex Philippidis
2 [GO] 2023―Feb―09 Developing the Next Generation of SARS-CoV-2 Vaccines Mark J. Newman
3 [GO] 2022―Dec―28 Wide Shot: Jacob Glanville Pursues Broad-Spectrum Vaccines vs. Pandemics Alex Philippidis
4 [GO] 2022―Dec―20 Pfizer and Clear Creek Bio to Collaborate on COVID-19 Antiviral Research Program Jonathan D Grinstein
5 [GO] 2022―Nov―02 How COVID-19 Forever Changed the In Vitro Diagnostics Marketplace
6 [GO] 2022―Aug―10 StockWatch: Humanigen Wilts after COVID-19 Antibody Fails NIH Trial Alex Philippidis
7 [GO] 2022―Aug―10 StockWatch: Valneva, Novavax Stocks Swing with COVID-19 Developments Alex Philippidis
8 [GO] 2022―Apr―08 GEN Edge StockWatch: Investors Warm to Moderna's COVID-19 Sales, Vaccine Updates Alex Philippidis
9 [GO] 2022―Feb―14 AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19 Alex Philippidis
10 [GO] 2022―Feb―14 In the Chips: Draper Adapting Tissue Culture Platform vs. COVID-19 Alex Philippidis
11 [GO] 2022―Feb―14 Close to the Edge: Regeneron's George Yancopoulos and Aris Baras Discuss Company, COVID-19 Alex Philippidis, Kevin Davies
12 [GO] 2022―Feb―14 The COVID-19 Pandemic: Lessons for the Future Justin Sanchez
13 [GO] 2022―Feb―14 Now Hiring: COVID-19, VC Surge Fuels Biotech Job Gains in Massachusetts and California Alex Philippidis
14 [GO] 2022―Feb―14 Off Message: Dyadic Fights COVID-19 with a Fungus Alex Philippidis
15 [GO] 2022―Feb―14 Beyond COVID-19: AbCellera Partners with Moderna to Develop mRNA-Encoded Antibodies Alex Philippidis
16 [GO] 2022―Feb―14 Pardes Biosciences Advances Oral Antiviral Drug for SARS-CoV-2 Infections Jonathan D. Grinstein
17 [GO] 2022―Feb―14 From Pandemic to Pipeline: What's Next for Moderna? Alex Philippidis
18 [GO] 2022―Feb―07 A ‘Human' Touch vs. COVID-19 Alex Philippidis
19 [GO] 2022―Feb―07 Obsidian's SWFT Response to COVID-19 Alex Philippidis
20 [GO] 2022―Feb―07 Gene Therapy Pioneer, Regeneron Partner on Nasal Spray vs. COVID-19 Alex Philippidis
21 [GO] 2022―Feb―07 $500M Merger Boosts NeuroRx VIP Guided Missile vs. COVID-19 Alex Philippidis
22 [GO] 2022―Feb―07 Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths Alex Philippidis
23 [GO] 2022―Feb―07 Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing Alex Philippidis
24 [GO] 2022―Feb―07 Putting COVID-19 on the ‘Map' Alex Philippidis
25 [GO] 2022―Feb―07 COVID-19 Puts Spotlight on Artificial Intelligence Jonathan Block
26 [GO] 2022―Feb―07 One COVID-19 Shot, Two Approaches Alex Philippidis
27 [GO] 2022―Feb―07 Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
28 [GO] 2022―Feb―07 Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch Alex Philippidis
29 [GO] 2022―Feb―07 GenapSys Pursues Partnership with China CDC to Detect Coronavirus Alex Philippidis
30 [GO] 2022―Feb―07 Assessing Coronavirus Impact on Wall Street Alex Philippidis
31 [GO] 2022―Feb―07 Mammoth Pursues Coronavirus Partnership as It Grows CRISPR Ambitions Alex Philippidis
32 [GO] 2022―Feb―07 Synthetic Data for a Real Pandemic Alex Philippidis
 [1] 

32 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec